Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial).

Wykoff, Charles C

Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial). [electronic resource] - The British journal of ophthalmology Jul 2014 - 951-5 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1468-2079

10.1136/bjophthalmol-2013-304736 doi


Aged
Aged, 80 and over
Angiogenesis Inhibitors--adverse effects
Antibodies, Monoclonal, Humanized--therapeutic use
Exudates and Transudates
Female
Humans
Intravitreal Injections
Male
Middle Aged
Prospective Studies
Ranibizumab
Receptors, Vascular Endothelial Growth Factor--adverse effects
Recombinant Fusion Proteins--adverse effects
Single-Blind Method
Subretinal Fluid
Tomography, Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Visual Acuity--drug effects
Wet Macular Degeneration--diagnosis